{"id":"https://openalex.org/W4385669604","doi":"https://doi.org/10.1192/j.eurpsy.2023.814","title":"Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics","display_name":"Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4385669604","doi":"https://doi.org/10.1192/j.eurpsy.2023.814","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10434477"},"language":"en","primary_location":{"id":"doi:10.1192/j.eurpsy.2023.814","doi":"https://doi.org/10.1192/j.eurpsy.2023.814","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1192/j.eurpsy.2023.814","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E63C2AC6B325A47F4D785C36AB9BE5EE/S0924933823008143a.pdf/div-class-title-osteopenia-and-osteoporosis-associated-with-hyperprolactinemic-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E63C2AC6B325A47F4D785C36AB9BE5EE/S0924933823008143a.pdf/div-class-title-osteopenia-and-osteoporosis-associated-with-hyperprolactinemic-antipsychotics-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044900817","display_name":"Angel Luis Montejo","orcid":"https://orcid.org/0000-0003-4383-1333","observed_orcids":["https://orcid.org/0000-0003-4383-1333"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"A. L. Montejo","raw_affiliation_strings":["Psychiatry, University of Salamanca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University of Salamanca","institution_ids":["https://openalex.org/I184999862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004740219","display_name":"B\u00e1rbara Buch-Vicente","orcid":"https://orcid.org/0000-0003-0325-4957","observed_orcids":["https://orcid.org/0000-0003-0325-4957"]},"institutions":[{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"B. Buch","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), IBSAL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), IBSAL","institution_ids":["https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057960679","display_name":"Y. Santana","orcid":"https://orcid.org/0000-0003-4653-2558","observed_orcids":["https://orcid.org/0000-0003-4653-2558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Santana","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Mat\u00edas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Mat\u00edas","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092614705","display_name":"J. Mat\u00edas-Polo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Matias-Polo","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064847369","display_name":"Tom\u00e1s Mart\u00edn-Pinto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Mart\u00edn-Pinto","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Matos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Matos","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019557843","display_name":"Bruno A. C\u00f4rtes","orcid":"https://orcid.org/0000-0001-7970-514X","observed_orcids":["https://orcid.org/0000-0001-7970-514X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Cort\u00e9s","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. de Alarc\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. de Alarc\u00f3n","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042301319","display_name":"Clara Fombellida Velasco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Fombellida","raw_affiliation_strings":["Psychiatry, University Hospital, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry, University Hospital, Salamanca, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067646539","display_name":"Jose Manuel Acosta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. M. Acosta","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), IBSAL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), IBSAL","institution_ids":["https://openalex.org/I4210134045"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5044900817"],"corresponding_institution_ids":["https://openalex.org/I184999862"],"apc_list":{"value":2785,"currency":"USD","value_usd":2785},"apc_paid":{"value":2785,"currency":"USD","value_usd":2785},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":"S1","first_page":"S375","last_page":"S376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.35030001401901245,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":0.8629999756813049},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8980000019073486},{"id":"https://openalex.org/keywords/osteoporosis","display_name":"osteoporosis","score":0.8610000014305115},{"id":"https://openalex.org/keywords/osteopenia","display_name":"osteopenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.9359999895095825},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9760000109672546},{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":0.9589999914169312},{"id":"https://openalex.org/keywords/amisulpride","display_name":"amisulpride","score":0.9980000257492065},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.7070000171661377},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.6850000023841858},{"id":"https://openalex.org/keywords/peak-bone-mass","display_name":"peak bone mass","score":0.6600000262260437},{"id":"https://openalex.org/keywords/dexa-scan","display_name":"DEXA scan","score":0.5849999785423279},{"id":"https://openalex.org/keywords/drug-induced-bone-disease","display_name":"drug-induced bone disease","score":0.4050000011920929},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.7668641209602356},{"id":"https://openalex.org/C2777083390","wikidata":"https://www.wikidata.org/wiki/Q1367706","display_name":"Osteopenia","level":4,"score":0.7525320053100586},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.730388879776001},{"id":"https://openalex.org/C2778999636","wikidata":"https://www.wikidata.org/wiki/Q418785","display_name":"Amisulpride","level":4,"score":0.7145066261291504},{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.6871877312660217},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.6605798602104187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5524876117706299},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.44887661933898926},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.4410150945186615},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.4149259328842163},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39272889494895935},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.312766969203949},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.28465133905410767},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.23825323581695557},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1192/j.eurpsy.2023.814","doi":"https://doi.org/10.1192/j.eurpsy.2023.814","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1192/j.eurpsy.2023.814","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E63C2AC6B325A47F4D785C36AB9BE5EE/S0924933823008143a.pdf/div-class-title-osteopenia-and-osteoporosis-associated-with-hyperprolactinemic-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10434477","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10434477","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10434477/pdf/S0924933823008143a.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Psychiatry","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:14608f15474d4bf19297232261dd513c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/14608f15474d4bf19297232261dd513c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Psychiatry, Vol 66, Pp S375-S376 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1192/j.eurpsy.2023.814","doi":"https://doi.org/10.1192/j.eurpsy.2023.814","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1192/j.eurpsy.2023.814","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E63C2AC6B325A47F4D785C36AB9BE5EE/S0924933823008143a.pdf/div-class-title-osteopenia-and-osteoporosis-associated-with-hyperprolactinemic-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385669604.pdf","grobid_xml":"https://content.openalex.org/works/W4385669604.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217843230","https://openalex.org/W2299202580","https://openalex.org/W1230491582","https://openalex.org/W2012720659","https://openalex.org/W2075528262","https://openalex.org/W2156238188","https://openalex.org/W2055219683","https://openalex.org/W2058496087","https://openalex.org/W2522311601","https://openalex.org/W2057652738"],"abstract_inverted_index":{"Introduction":[0],"The":[1,21,134,215,222,295],"main":[2],"role":[3],"of":[4,39,55,66,69,93,125,150,165,206,217,241,267,300,328],"prolactin":[5,22,115,224,256],"is":[6,303],"associated":[7,57,282],"mainly":[8],"with":[9,27,58,76,127,174,235,244,249,254,272,283,289],"lactogenesis":[10],"but":[11],"additionally":[12],"it":[13],"participates":[14],"in":[15,63,90,147,155,226,305],"several":[16],"endocrinological":[17],"and":[18,34,48,74,87,119,142,154,172,247,261,269,279,297,322],"metabolic":[19],"processes.":[20],"level":[23,196,225],"may":[24],"be":[25,316],"increased":[26,292],"some":[28,211],"antipsychotics":[29,77,105],"such":[30],"as":[31],"risperidone,":[32],"paliperidone,":[33],"amisulpride":[35],"increasing":[36],"the":[37,53,139,143,148,151,156,188,201,227,265,270,301],"risk":[38],"Bone":[40],"Mineral":[41],"Mass":[42],"(BMM)":[43],"decrease":[44],"leading":[45],"to":[46,308,318,323],"osteopenia":[47],"osteoporosis.":[49],"Objectives":[50],"To":[51],"determine":[52],"loss":[54],"BMM":[56,126,212,302],"antipsychotic-related":[59],"iatrogenic":[60],"hyperprolactinemia":[61],"(iHPRL)":[62],"a":[64,91,128,238,290],"sample":[65,92,228],"patients":[67,95,208,307],"suffering":[68],"chronic":[70],"psychotic":[71,166],"mental":[72],"disorder":[73],"treated":[75],"at":[78,177],"least":[79,178],"for":[80,179],"one":[81,180],"year.":[82,181],"Methods":[83],"A":[84,194,259],"cross-sectional":[85],"observational":[86],"epidemiological":[88],"study":[89],"140":[94,207],"(males":[96],"56.9%;":[97],"females":[98],"43.1%;":[99],"mean":[100],"age":[101,141,168],"48":[102],"years),":[103],"receiving":[104],"was":[106,132,160,184,198,219,229,274,287],"carried":[107,185],"out.":[108],"After":[109],"giving":[110],"informed":[111],"consent,":[112],"personal":[113],"data,":[114],"level,":[116],"antipsychotic":[117,176],"use":[118],"lifestyle":[120],"were":[121],"collected.":[122],"An":[123],"evaluation":[124],"central":[129],"DEXA":[130],"Scan":[131],"performed.":[133],"bone":[135,145,311,320],"mineral":[136],"density":[137],"considering":[138],"subject\u00b4s":[140],"peak":[144],"mass":[146],"neck":[149],"femur,":[152],"hip":[153],"lumbar":[157],"vertebrae":[158],"(L1-L4)":[159],"obtained.":[161],"Inclusion":[162],"criteria:":[163],"presence":[164,266],"disorder,":[167],"between":[169,264],"18-65":[170],"years":[171],"treatment":[173,271],"an":[175],"Statistical":[182],"analysis":[183],"out":[186,205],"using":[187],"statistical":[189],"software":[190],"SPSS":[191],"version":[192],"26.0.":[193],"significance":[195],"\u03b1=0.05":[197],"considered":[199],"throughout":[200],"study.":[202],"Results":[203],"45":[204],"(32,13%)":[209],"had":[210],"lost":[213],"(osteopenia).":[214],"prevalence":[216],"osteoporosis":[218,268,280,293],"5.71%":[220],"(n=8).":[221],"median":[223],"46.1":[230],"ng/dL":[231],"\u00b1":[232],"33.1.":[233],"Patients":[234],"hyperprolactinaemia":[236],"showed":[237],"higher":[239],"frequency":[240],"osteopenia/osteoporosis":[242],"(50%":[243],"mild":[245],"iHPRL":[246],"48%":[248],"moderate/severe":[250],"iHPRL)":[251],"than":[252],"those":[253],"normal":[255],"levels":[257],"(25.7%).":[258],"strong":[260],"significant":[262,291],"relationship":[263],"risperidone":[273],"found":[275],"(p=0.007).":[276],"Conclusions":[277],"Osteopenia":[278],"are":[281],"hyperprolactinemic":[284],"antipsychotic.":[285],"Risperidone":[286],"related":[288],"risk.":[294],"rutinary":[296],"systematic":[298],"control":[299],"crucial":[304],"these":[306],"avoid":[309,319],"progressive":[310],"demineralization.":[312],"Managing":[313],"strategies":[314],"should":[315],"individualized":[317],"demineralization":[321],"preserve":[324],"physical":[325],"health.":[326],"Disclosure":[327],"Interest":[329],"None":[330],"Declared":[331]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-08-09T00:00:00"}